Literature DB >> 8441377

Dimerization of NF-KB2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD-3).

C S Duckett1, N D Perkins, T F Kowalik, R M Schmid, E S Huang, A S Baldwin, G J Nabel.   

Abstract

Inducible expression of human immunodeficiency virus (HIV) is regulated by a cellular transcription factor, nuclear factor kappa B (NF-kappa B). NF-kappa B is composed of distinct subunits; five independent genes, NFKB1(p105), NFKB2(p100), RelA(p65), c-rel and relB, that encode related proteins that bind to kappa B DNA elements have been isolated. We have previously found that NFKB2(p49/p52) acts in concert with RelA(p65) to stimulate the HIV enhancer in Jurkat T-leukemia cells. Here we examine the biochemical basis for the transcriptional regulation of HIV by NFKB2. Using Scatchard analysis, we have determined the dissociation constants of homodimeric p49 and heterodimeric p49/p65 for binding to the HIV kappa B site. p49 has a approximately 18-fold-lower affinity for the HIV kappa B site (KD = 69.1 pM) than does the approximately 50-kDa protein NFKB1(p50) derived from p105 (KD = 3.9 pM). In contrast, the affinity of heterodimeric NFKB2(p49)/RelA(p65) for this site is approximately 6-fold higher (KD = 11.8 pM) than that of p49 alone. Consistent with these findings, in vitro transcription was stimulated 18-fold by the addition of preformed, heterodimeric NFKB2(p49)/RelA(p65) protein. Transcriptional activation of the HIV enhancer was also subject to regulation by recently cloned I kappa B-alpha(MAD-3). Recombinant I kappa B-alpha(MAD-3) inhibited the DNA binding activity of p65, p49/p65, and p50/p65 but stimulated the binding of NFKB2(p49) or NFKB1(p50). Functional activation of an HIV reporter plasmid by p49/p65 in transiently transfected Jurkat T-leukemia cells was also inhibited by coexpression of MAD-3. These data suggest that binding of the NFKB2 subunit to the HIV enhancer is facilitated by RelA(p65) and that this NFKB2(p49)/p65 heterodimeric complex mediates transcriptional activation which is subject to regulation by MAD-3.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8441377      PMCID: PMC359440          DOI: 10.1128/mcb.13.3.1315-1322.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  49 in total

1.  Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B.

Authors:  T Fujita; G P Nolan; S Ghosh; D Baltimore
Journal:  Genes Dev       Date:  1992-05       Impact factor: 11.361

2.  Affinity purification of sequence-specific DNA binding proteins.

Authors:  J T Kadonaga; R Tjian
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

3.  Factors involved in specific transcription by human RNA polymerase II: analysis by a rapid and quantitative in vitro assay.

Authors:  M Sawadogo; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

4.  A common positive trans-acting factor binds to enhancer sequences in the promoters of mouse H-2 and beta 2-microglobulin genes.

Authors:  A Israël; A Kimura; M Kieran; O Yano; J Kanellopoulos; O Le Bail; P Kourilsky
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

5.  Binding of a nuclear factor to a regulatory sequence in the promoter of the mouse H-2Kb class I major histocompatibility gene.

Authors:  A S Baldwin; P A Sharp
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

6.  Dorsal, an embryonic polarity gene in Drosophila, is homologous to the vertebrate proto-oncogene, c-rel.

Authors:  R Steward
Journal:  Science       Date:  1987-10-30       Impact factor: 47.728

7.  An inducible transcription factor activates expression of human immunodeficiency virus in T cells.

Authors:  G Nabel; D Baltimore
Journal:  Nature       Date:  1987 Apr 16-22       Impact factor: 49.962

8.  Related subunits of NF-kappa B map to two distinct loci associated with translocations in leukemia, NFKB1 and NFKB2.

Authors:  S Liptay; R M Schmid; N D Perkins; P Meltzer; M R Altherr; J D McPherson; J J Wasmuth; G J Nabel
Journal:  Genomics       Date:  1992-06       Impact factor: 5.736

9.  The NF-kappa B p50 precursor, p105, contains an internal I kappa B-like inhibitor that preferentially inhibits p50.

Authors:  H C Liou; G P Nolan; S Ghosh; T Fujita; D Baltimore
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

10.  Purification of KBF1, a common factor binding to both H-2 and beta 2-microglobulin enhancers.

Authors:  O Yano; J Kanellopoulos; M Kieran; O Le Bail; A Israël; P Kourilsky
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

View more
  55 in total

1.  The effects of calpain inhibition on IkB alpha degradation after activation of PBMCs: identification of the calpain cleavage sites.

Authors:  Kurt Schaecher; Jean-Michel Goust; Naren L Banik
Journal:  Neurochem Res       Date:  2004-07       Impact factor: 3.996

2.  Tumor necrosis factor-α represses the expression of NHE2 through NF-κB activation in intestinal epithelial cell model, C2BBe1.

Authors:  Md Ruhul Amin; Temitope Orenuga; Sangeeta Tyagi; Pradeep K Dudeja; Krishnamurthy Ramaswamy; Jaleh Malakooti
Journal:  Inflamm Bowel Dis       Date:  2010-08-18       Impact factor: 5.325

3.  Protein methyltransferase 2 inhibits NF-kappaB function and promotes apoptosis.

Authors:  Lakshmanan Ganesh; Takanobu Yoshimoto; Narayani C Moorthy; Wataru Akahata; Manfred Boehm; Elizabeth G Nabel; Gary J Nabel
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

4.  Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit.

Authors:  Katie Schumm; Sonia Rocha; Jorge Caamano; Neil D Perkins
Journal:  EMBO J       Date:  2006-09-21       Impact factor: 11.598

5.  A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors.

Authors:  C S Duckett; V E Nava; R W Gedrich; R J Clem; J L Van Dongen; M C Gilfillan; H Shiels; J M Hardwick; C B Thompson
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

6.  Phosphorylation of IkappaBalpha in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability.

Authors:  R Lin; P Beauparlant; C Makris; S Meloche; J Hiscott
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

7.  A new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription.

Authors:  Z Li; G J Nabel
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

8.  Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B.

Authors:  Prim de Bie; Bart van de Sluis; Ezra Burstein; Peter V E van de Berghe; Patricia Muller; Ruud Berger; Jonathan D Gitlin; Cisca Wijmenga; Leo W J Klomp
Journal:  Gastroenterology       Date:  2007-07-25       Impact factor: 22.682

9.  Nuclear factor-kappaB binds to the Epstein-Barr Virus LMP1 promoter and upregulates its expression.

Authors:  Pegah Johansson; Ann Jansson; Ulla Rüetschi; Lars Rymo
Journal:  J Virol       Date:  2008-11-19       Impact factor: 5.103

10.  TAp63 is a transcriptional target of NF-kappaB.

Authors:  Junfeng Wu; Johann Bergholz; Jinin Lu; Gail E Sonenshein; Zhi-Xiong Jim Xiao
Journal:  J Cell Biochem       Date:  2010-03-01       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.